You are here: Industry Insights > COVID-19

News List

Ampio Provides Update on COVID-19 Clinical Trial Activities prnewswire
August 20, 2020
?Ampio Pharmaceuticals, Inc., a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, provides updates regarding the following clinical trials.
vybe urgent care Offers Rapid COVID-19 Testing for Employers and Consumers prnewswire
August 20, 2020
vybe urgent care, the leading independent operator of urgent care centers in the Philadelphia area, announces a rapid test for COVID-19 from Quidel that provides a result in 15 minutes.
Hoth Therapeutics Provides Shareholder Update on COVID-19 Initiatives and Dermatological Therapy Pipeline prnewswire
August 20, 2020
Hoth Therapeutics, Inc., a biopharmaceutical company, today is providing shareholders with a update on its COVID-19 initiatives including vaccine and real-time, breath-based mobile testing device as well as its dermatological therapy pipeline.
Hackensack Meridian Health Observational Study Identifies Drug that Improves Survival in Sickest COVID-19 Patients prnewswire
August 20, 2020
Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in ...
Observational study identifies drug that improves survival in sickest COVID-19 patients worldpharmanews
August 20, 2020
Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid ...
BOLD-100 significantly outperforms remdesivir head-to-head in SARS-CoV-2 model pharmaceutical-business-review
August 20, 2020
Bold Therapeutics, a clinical-stage biopharmaceutical company, recently generated additional data supporting rapid clinical development of BOLD-100 as a novel antiviral.
Agilent to invest $150m for expansion of Frederick production facility in US pharmaceutical-business-review
August 20, 2020
Agilent Technologies has announced an investment of up to $150m to expand its production facility for nucleic acid-based therapeutics in the US.
FDA Issues EUA to Yale School of Public Health for SalivaDirect COVID-19 Test americanpharmaceuticalreview
August 20, 2020
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Yale School of Public Health for its SalivaDirect COVID-19 diagnostic test, which uses a new method of processing saliva samples when testing for COVID-19 infection
BioSymetrics, Janssen Enter AI Prediction Alliance for COVID-19 contractpharma
August 20, 2020
Will focus on predicting the onset and severity of COVID-19 among different populations using machine learning.
Roche, Regeneron Partner to Increase Global Supply of REGN-COV2 contractpharma
August 20, 2020
To develop, manufacture and distribute REGN-COV2, Regeneron’s investigational antiviral antibody combination to treat COVID-19.